nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—Sildenafil—CYP2E1—liver cancer	0.00953	0.503	CrCbGaD
Vardenafil—Sildenafil—CYP1A1—liver cancer	0.0094	0.497	CrCbGaD
Vardenafil—Myocardial infarction—Sorafenib—liver cancer	0.00419	0.00742	CcSEcCtD
Vardenafil—Redness—Epirubicin—liver cancer	0.00419	0.00741	CcSEcCtD
Vardenafil—Haematemesis—Epirubicin—liver cancer	0.00407	0.0072	CcSEcCtD
Vardenafil—Burning sensation—Epirubicin—liver cancer	0.00407	0.0072	CcSEcCtD
Vardenafil—Hepatobiliary disease—Sorafenib—liver cancer	0.00405	0.00716	CcSEcCtD
Vardenafil—Epistaxis—Sorafenib—liver cancer	0.00404	0.00714	CcSEcCtD
Vardenafil—Redness—Doxorubicin—liver cancer	0.00388	0.00686	CcSEcCtD
Vardenafil—Haemoglobin—Sorafenib—liver cancer	0.00386	0.00683	CcSEcCtD
Vardenafil—Haemorrhage—Sorafenib—liver cancer	0.00384	0.0068	CcSEcCtD
Vardenafil—Ventricular arrhythmia—Epirubicin—liver cancer	0.00382	0.00676	CcSEcCtD
Vardenafil—Urinary tract disorder—Sorafenib—liver cancer	0.00379	0.00671	CcSEcCtD
Vardenafil—Connective tissue disorder—Sorafenib—liver cancer	0.00378	0.00668	CcSEcCtD
Vardenafil—Urethral disorder—Sorafenib—liver cancer	0.00377	0.00666	CcSEcCtD
Vardenafil—Haematemesis—Doxorubicin—liver cancer	0.00377	0.00666	CcSEcCtD
Vardenafil—Burning sensation—Doxorubicin—liver cancer	0.00377	0.00666	CcSEcCtD
Vardenafil—Scotoma—Epirubicin—liver cancer	0.00372	0.00659	CcSEcCtD
Vardenafil—Feeling hot—Epirubicin—liver cancer	0.0036	0.00637	CcSEcCtD
Vardenafil—Tinnitus—Sorafenib—liver cancer	0.00358	0.00634	CcSEcCtD
Vardenafil—Cardiac disorder—Sorafenib—liver cancer	0.00357	0.00631	CcSEcCtD
Vardenafil—Flushing—Sorafenib—liver cancer	0.00357	0.00631	CcSEcCtD
Vardenafil—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00353	0.00625	CcSEcCtD
Vardenafil—Angiopathy—Sorafenib—liver cancer	0.00349	0.00617	CcSEcCtD
Vardenafil—Immune system disorder—Sorafenib—liver cancer	0.00347	0.00614	CcSEcCtD
Vardenafil—Mediastinal disorder—Sorafenib—liver cancer	0.00346	0.00613	CcSEcCtD
Vardenafil—Scotoma—Doxorubicin—liver cancer	0.00344	0.00609	CcSEcCtD
Vardenafil—Mental disorder—Sorafenib—liver cancer	0.00337	0.00595	CcSEcCtD
Vardenafil—Erythema—Sorafenib—liver cancer	0.00334	0.00592	CcSEcCtD
Vardenafil—Feeling hot—Doxorubicin—liver cancer	0.00333	0.0059	CcSEcCtD
Vardenafil—Cardiovascular disorder—Epirubicin—liver cancer	0.00322	0.00569	CcSEcCtD
Vardenafil—Muscle spasms—Sorafenib—liver cancer	0.00322	0.00569	CcSEcCtD
Vardenafil—Lacrimation increased—Epirubicin—liver cancer	0.00307	0.00543	CcSEcCtD
Vardenafil—Angioedema—Sorafenib—liver cancer	0.00306	0.00541	CcSEcCtD
Vardenafil—Syncope—Sorafenib—liver cancer	0.003	0.00531	CcSEcCtD
Vardenafil—Cardiovascular disorder—Doxorubicin—liver cancer	0.00298	0.00527	CcSEcCtD
Vardenafil—Creatinine increased—Epirubicin—liver cancer	0.00297	0.00525	CcSEcCtD
Vardenafil—Loss of consciousness—Sorafenib—liver cancer	0.00294	0.0052	CcSEcCtD
Vardenafil—Neck pain—Epirubicin—liver cancer	0.00286	0.00506	CcSEcCtD
Vardenafil—Myalgia—Sorafenib—liver cancer	0.00285	0.00504	CcSEcCtD
Vardenafil—Arthralgia—Sorafenib—liver cancer	0.00285	0.00504	CcSEcCtD
Vardenafil—Lacrimation increased—Doxorubicin—liver cancer	0.00284	0.00502	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00283	0.005	CcSEcCtD
Vardenafil—Dry mouth—Sorafenib—liver cancer	0.00278	0.00493	CcSEcCtD
Vardenafil—Creatinine increased—Doxorubicin—liver cancer	0.00275	0.00486	CcSEcCtD
Vardenafil—Influenza like illness—Epirubicin—liver cancer	0.00275	0.00486	CcSEcCtD
Vardenafil—Anaphylactic shock—Sorafenib—liver cancer	0.00273	0.00483	CcSEcCtD
Vardenafil—Infection—Sorafenib—liver cancer	0.00271	0.0048	CcSEcCtD
Vardenafil—Shock—Sorafenib—liver cancer	0.00269	0.00475	CcSEcCtD
Vardenafil—Nervous system disorder—Sorafenib—liver cancer	0.00268	0.00474	CcSEcCtD
Vardenafil—Skin disorder—Sorafenib—liver cancer	0.00265	0.00469	CcSEcCtD
Vardenafil—Neck pain—Doxorubicin—liver cancer	0.00265	0.00468	CcSEcCtD
Vardenafil—Oesophagitis—Epirubicin—liver cancer	0.00258	0.00457	CcSEcCtD
Vardenafil—Influenza like illness—Doxorubicin—liver cancer	0.00254	0.00449	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00249	0.0044	CcSEcCtD
Vardenafil—Hypertonia—Epirubicin—liver cancer	0.00248	0.00438	CcSEcCtD
Vardenafil—Abnormal vision—Epirubicin—liver cancer	0.00247	0.00436	CcSEcCtD
Vardenafil—Dyspnoea—Sorafenib—liver cancer	0.00243	0.00431	CcSEcCtD
Vardenafil—Dyspepsia—Sorafenib—liver cancer	0.0024	0.00425	CcSEcCtD
Vardenafil—Oesophagitis—Doxorubicin—liver cancer	0.00239	0.00423	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Sorafenib—liver cancer	0.00236	0.00417	CcSEcCtD
Vardenafil—Pain—Sorafenib—liver cancer	0.00233	0.00413	CcSEcCtD
Vardenafil—Hypertonia—Doxorubicin—liver cancer	0.00229	0.00406	CcSEcCtD
Vardenafil—Abnormal vision—Doxorubicin—liver cancer	0.00228	0.00404	CcSEcCtD
Vardenafil—Eye pain—Epirubicin—liver cancer	0.00227	0.00402	CcSEcCtD
Vardenafil—Gastrointestinal pain—Sorafenib—liver cancer	0.00223	0.00395	CcSEcCtD
Vardenafil—Hot flush—Epirubicin—liver cancer	0.00219	0.00388	CcSEcCtD
Vardenafil—Menopausal symptoms—Epirubicin—liver cancer	0.00218	0.00385	CcSEcCtD
Vardenafil—Abdominal pain—Sorafenib—liver cancer	0.00216	0.00382	CcSEcCtD
Vardenafil—Eye pain—Doxorubicin—liver cancer	0.0021	0.00372	CcSEcCtD
Vardenafil—Hot flush—Doxorubicin—liver cancer	0.00203	0.00359	CcSEcCtD
Vardenafil—Menopausal symptoms—Doxorubicin—liver cancer	0.00201	0.00356	CcSEcCtD
Vardenafil—Hypersensitivity—Sorafenib—liver cancer	0.00201	0.00356	CcSEcCtD
Vardenafil—Face oedema—Epirubicin—liver cancer	0.00198	0.00351	CcSEcCtD
Vardenafil—Asthenia—Sorafenib—liver cancer	0.00196	0.00346	CcSEcCtD
Vardenafil—Pruritus—Sorafenib—liver cancer	0.00193	0.00342	CcSEcCtD
Vardenafil—Blood creatinine increased—Epirubicin—liver cancer	0.00192	0.0034	CcSEcCtD
Vardenafil—Liver function test abnormal—Epirubicin—liver cancer	0.00189	0.00335	CcSEcCtD
Vardenafil—Orthostatic hypotension—Epirubicin—liver cancer	0.00187	0.00332	CcSEcCtD
Vardenafil—Abdominal pain upper—Epirubicin—liver cancer	0.00187	0.00332	CcSEcCtD
Vardenafil—Diarrhoea—Sorafenib—liver cancer	0.00187	0.0033	CcSEcCtD
Vardenafil—Breast disorder—Epirubicin—liver cancer	0.00185	0.00328	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00185	0.00327	CcSEcCtD
Vardenafil—Face oedema—Doxorubicin—liver cancer	0.00183	0.00324	CcSEcCtD
Vardenafil—Gastritis—Epirubicin—liver cancer	0.00182	0.00321	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00181	0.0032	CcSEcCtD
Vardenafil—Dizziness—Sorafenib—liver cancer	0.0018	0.00319	CcSEcCtD
Vardenafil—Blood creatinine increased—Doxorubicin—liver cancer	0.00178	0.00315	CcSEcCtD
Vardenafil—Influenza—Epirubicin—liver cancer	0.00177	0.00314	CcSEcCtD
Vardenafil—Dysphagia—Epirubicin—liver cancer	0.00177	0.00314	CcSEcCtD
Vardenafil—Liver function test abnormal—Doxorubicin—liver cancer	0.00175	0.0031	CcSEcCtD
Vardenafil—Vomiting—Sorafenib—liver cancer	0.00174	0.00307	CcSEcCtD
Vardenafil—Orthostatic hypotension—Doxorubicin—liver cancer	0.00173	0.00307	CcSEcCtD
Vardenafil—Abdominal pain upper—Doxorubicin—liver cancer	0.00173	0.00307	CcSEcCtD
Vardenafil—Angina pectoris—Epirubicin—liver cancer	0.00173	0.00306	CcSEcCtD
Vardenafil—Rash—Sorafenib—liver cancer	0.00172	0.00304	CcSEcCtD
Vardenafil—Dermatitis—Sorafenib—liver cancer	0.00172	0.00304	CcSEcCtD
Vardenafil—Breast disorder—Doxorubicin—liver cancer	0.00172	0.00304	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00171	0.00303	CcSEcCtD
Vardenafil—Headache—Sorafenib—liver cancer	0.00171	0.00303	CcSEcCtD
Vardenafil—Gastritis—Doxorubicin—liver cancer	0.00168	0.00297	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00167	0.00296	CcSEcCtD
Vardenafil—Influenza—Doxorubicin—liver cancer	0.00164	0.0029	CcSEcCtD
Vardenafil—Dysphagia—Doxorubicin—liver cancer	0.00164	0.0029	CcSEcCtD
Vardenafil—Nausea—Sorafenib—liver cancer	0.00162	0.00287	CcSEcCtD
Vardenafil—Photosensitivity reaction—Epirubicin—liver cancer	0.00162	0.00286	CcSEcCtD
Vardenafil—Angina pectoris—Doxorubicin—liver cancer	0.0016	0.00283	CcSEcCtD
Vardenafil—Infestation—Epirubicin—liver cancer	0.00158	0.0028	CcSEcCtD
Vardenafil—Infestation NOS—Epirubicin—liver cancer	0.00158	0.0028	CcSEcCtD
Vardenafil—Conjunctivitis—Epirubicin—liver cancer	0.00154	0.00272	CcSEcCtD
Vardenafil—Sweating—Epirubicin—liver cancer	0.00152	0.00268	CcSEcCtD
Vardenafil—Haematuria—Epirubicin—liver cancer	0.00151	0.00267	CcSEcCtD
Vardenafil—Photosensitivity reaction—Doxorubicin—liver cancer	0.0015	0.00265	CcSEcCtD
Vardenafil—Hepatobiliary disease—Epirubicin—liver cancer	0.0015	0.00265	CcSEcCtD
Vardenafil—Epistaxis—Epirubicin—liver cancer	0.00149	0.00264	CcSEcCtD
Vardenafil—Sinusitis—Epirubicin—liver cancer	0.00148	0.00263	CcSEcCtD
Vardenafil—Infestation NOS—Doxorubicin—liver cancer	0.00146	0.00259	CcSEcCtD
Vardenafil—Infestation—Doxorubicin—liver cancer	0.00146	0.00259	CcSEcCtD
Vardenafil—Haemoglobin—Epirubicin—liver cancer	0.00143	0.00252	CcSEcCtD
Vardenafil—Rhinitis—Epirubicin—liver cancer	0.00142	0.00252	CcSEcCtD
Vardenafil—Conjunctivitis—Doxorubicin—liver cancer	0.00142	0.00252	CcSEcCtD
Vardenafil—Haemorrhage—Epirubicin—liver cancer	0.00142	0.00251	CcSEcCtD
Vardenafil—Hypoaesthesia—Epirubicin—liver cancer	0.00141	0.0025	CcSEcCtD
Vardenafil—Pharyngitis—Epirubicin—liver cancer	0.00141	0.00249	CcSEcCtD
Vardenafil—Sweating—Doxorubicin—liver cancer	0.0014	0.00248	CcSEcCtD
Vardenafil—Urinary tract disorder—Epirubicin—liver cancer	0.0014	0.00248	CcSEcCtD
Vardenafil—Haematuria—Doxorubicin—liver cancer	0.0014	0.00247	CcSEcCtD
Vardenafil—Connective tissue disorder—Epirubicin—liver cancer	0.0014	0.00247	CcSEcCtD
Vardenafil—Urethral disorder—Epirubicin—liver cancer	0.00139	0.00246	CcSEcCtD
Vardenafil—Hepatobiliary disease—Doxorubicin—liver cancer	0.00138	0.00245	CcSEcCtD
Vardenafil—Epistaxis—Doxorubicin—liver cancer	0.00138	0.00244	CcSEcCtD
Vardenafil—Sinusitis—Doxorubicin—liver cancer	0.00137	0.00243	CcSEcCtD
Vardenafil—Visual impairment—Epirubicin—liver cancer	0.00137	0.00242	CcSEcCtD
Vardenafil—Eye disorder—Epirubicin—liver cancer	0.00133	0.00235	CcSEcCtD
Vardenafil—Tinnitus—Epirubicin—liver cancer	0.00132	0.00234	CcSEcCtD
Vardenafil—Haemoglobin—Doxorubicin—liver cancer	0.00132	0.00234	CcSEcCtD
Vardenafil—Flushing—Epirubicin—liver cancer	0.00132	0.00233	CcSEcCtD
Vardenafil—Cardiac disorder—Epirubicin—liver cancer	0.00132	0.00233	CcSEcCtD
Vardenafil—Rhinitis—Doxorubicin—liver cancer	0.00132	0.00233	CcSEcCtD
Vardenafil—Haemorrhage—Doxorubicin—liver cancer	0.00131	0.00232	CcSEcCtD
Vardenafil—Hypoaesthesia—Doxorubicin—liver cancer	0.00131	0.00231	CcSEcCtD
Vardenafil—Pharyngitis—Doxorubicin—liver cancer	0.0013	0.00231	CcSEcCtD
Vardenafil—Urinary tract disorder—Doxorubicin—liver cancer	0.0013	0.0023	CcSEcCtD
Vardenafil—Connective tissue disorder—Doxorubicin—liver cancer	0.00129	0.00228	CcSEcCtD
Vardenafil—Angiopathy—Epirubicin—liver cancer	0.00129	0.00228	CcSEcCtD
Vardenafil—Urethral disorder—Doxorubicin—liver cancer	0.00129	0.00228	CcSEcCtD
Vardenafil—Immune system disorder—Epirubicin—liver cancer	0.00128	0.00227	CcSEcCtD
Vardenafil—Mediastinal disorder—Epirubicin—liver cancer	0.00128	0.00226	CcSEcCtD
Vardenafil—Visual impairment—Doxorubicin—liver cancer	0.00127	0.00224	CcSEcCtD
Vardenafil—Mental disorder—Epirubicin—liver cancer	0.00124	0.0022	CcSEcCtD
Vardenafil—Erythema—Epirubicin—liver cancer	0.00124	0.00219	CcSEcCtD
Vardenafil—Eye disorder—Doxorubicin—liver cancer	0.00123	0.00217	CcSEcCtD
Vardenafil—Tinnitus—Doxorubicin—liver cancer	0.00122	0.00217	CcSEcCtD
Vardenafil—Cardiac disorder—Doxorubicin—liver cancer	0.00122	0.00216	CcSEcCtD
Vardenafil—Flushing—Doxorubicin—liver cancer	0.00122	0.00216	CcSEcCtD
Vardenafil—Back pain—Epirubicin—liver cancer	0.0012	0.00212	CcSEcCtD
Vardenafil—Angiopathy—Doxorubicin—liver cancer	0.00119	0.00211	CcSEcCtD
Vardenafil—Muscle spasms—Epirubicin—liver cancer	0.00119	0.0021	CcSEcCtD
Vardenafil—Immune system disorder—Doxorubicin—liver cancer	0.00119	0.0021	CcSEcCtD
Vardenafil—Mediastinal disorder—Doxorubicin—liver cancer	0.00118	0.00209	CcSEcCtD
Vardenafil—Vision blurred—Epirubicin—liver cancer	0.00116	0.00206	CcSEcCtD
Vardenafil—Mental disorder—Doxorubicin—liver cancer	0.00115	0.00204	CcSEcCtD
Vardenafil—Ill-defined disorder—Epirubicin—liver cancer	0.00115	0.00203	CcSEcCtD
Vardenafil—Erythema—Doxorubicin—liver cancer	0.00114	0.00202	CcSEcCtD
Vardenafil—Malaise—Epirubicin—liver cancer	0.00111	0.00197	CcSEcCtD
Vardenafil—Vertigo—Epirubicin—liver cancer	0.00111	0.00196	CcSEcCtD
Vardenafil—Syncope—Epirubicin—liver cancer	0.00111	0.00196	CcSEcCtD
Vardenafil—Back pain—Doxorubicin—liver cancer	0.00111	0.00196	CcSEcCtD
Vardenafil—Muscle spasms—Doxorubicin—liver cancer	0.0011	0.00195	CcSEcCtD
Vardenafil—Palpitations—Epirubicin—liver cancer	0.00109	0.00193	CcSEcCtD
Vardenafil—Loss of consciousness—Epirubicin—liver cancer	0.00109	0.00192	CcSEcCtD
Vardenafil—Vision blurred—Doxorubicin—liver cancer	0.00108	0.00191	CcSEcCtD
Vardenafil—Convulsion—Epirubicin—liver cancer	0.00107	0.00189	CcSEcCtD
Vardenafil—Ill-defined disorder—Doxorubicin—liver cancer	0.00106	0.00188	CcSEcCtD
Vardenafil—Arthralgia—Epirubicin—liver cancer	0.00105	0.00186	CcSEcCtD
Vardenafil—Myalgia—Epirubicin—liver cancer	0.00105	0.00186	CcSEcCtD
Vardenafil—Chest pain—Epirubicin—liver cancer	0.00105	0.00186	CcSEcCtD
Vardenafil—Anxiety—Epirubicin—liver cancer	0.00105	0.00186	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00104	0.00185	CcSEcCtD
Vardenafil—Discomfort—Epirubicin—liver cancer	0.00104	0.00184	CcSEcCtD
Vardenafil—Malaise—Doxorubicin—liver cancer	0.00103	0.00182	CcSEcCtD
Vardenafil—Dry mouth—Epirubicin—liver cancer	0.00103	0.00182	CcSEcCtD
Vardenafil—Vertigo—Doxorubicin—liver cancer	0.00103	0.00182	CcSEcCtD
Vardenafil—Syncope—Doxorubicin—liver cancer	0.00103	0.00181	CcSEcCtD
Vardenafil—Palpitations—Doxorubicin—liver cancer	0.00101	0.00179	CcSEcCtD
Vardenafil—Anaphylactic shock—Epirubicin—liver cancer	0.00101	0.00178	CcSEcCtD
Vardenafil—Loss of consciousness—Doxorubicin—liver cancer	0.00101	0.00178	CcSEcCtD
Vardenafil—Infection—Epirubicin—liver cancer	0.001	0.00177	CcSEcCtD
Vardenafil—Shock—Epirubicin—liver cancer	0.000992	0.00176	CcSEcCtD
Vardenafil—Convulsion—Doxorubicin—liver cancer	0.000991	0.00175	CcSEcCtD
Vardenafil—Nervous system disorder—Epirubicin—liver cancer	0.000989	0.00175	CcSEcCtD
Vardenafil—Tachycardia—Epirubicin—liver cancer	0.000984	0.00174	CcSEcCtD
Vardenafil—Skin disorder—Epirubicin—liver cancer	0.00098	0.00173	CcSEcCtD
Vardenafil—Hyperhidrosis—Epirubicin—liver cancer	0.000975	0.00173	CcSEcCtD
Vardenafil—Myalgia—Doxorubicin—liver cancer	0.000974	0.00172	CcSEcCtD
Vardenafil—Arthralgia—Doxorubicin—liver cancer	0.000974	0.00172	CcSEcCtD
Vardenafil—Chest pain—Doxorubicin—liver cancer	0.000974	0.00172	CcSEcCtD
Vardenafil—Anxiety—Doxorubicin—liver cancer	0.00097	0.00172	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000967	0.00171	CcSEcCtD
Vardenafil—Discomfort—Doxorubicin—liver cancer	0.000962	0.0017	CcSEcCtD
Vardenafil—Dry mouth—Doxorubicin—liver cancer	0.000952	0.00168	CcSEcCtD
Vardenafil—Hypotension—Epirubicin—liver cancer	0.000943	0.00167	CcSEcCtD
Vardenafil—Anaphylactic shock—Doxorubicin—liver cancer	0.000933	0.00165	CcSEcCtD
Vardenafil—Infection—Doxorubicin—liver cancer	0.000927	0.00164	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000919	0.00163	CcSEcCtD
Vardenafil—Shock—Doxorubicin—liver cancer	0.000918	0.00162	CcSEcCtD
Vardenafil—Nervous system disorder—Doxorubicin—liver cancer	0.000915	0.00162	CcSEcCtD
Vardenafil—Insomnia—Epirubicin—liver cancer	0.000912	0.00161	CcSEcCtD
Vardenafil—Tachycardia—Doxorubicin—liver cancer	0.000911	0.00161	CcSEcCtD
Vardenafil—Skin disorder—Doxorubicin—liver cancer	0.000907	0.0016	CcSEcCtD
Vardenafil—Paraesthesia—Epirubicin—liver cancer	0.000906	0.0016	CcSEcCtD
Vardenafil—Hyperhidrosis—Doxorubicin—liver cancer	0.000902	0.0016	CcSEcCtD
Vardenafil—Dyspnoea—Epirubicin—liver cancer	0.000899	0.00159	CcSEcCtD
Vardenafil—Somnolence—Epirubicin—liver cancer	0.000897	0.00159	CcSEcCtD
Vardenafil—Dyspepsia—Epirubicin—liver cancer	0.000888	0.00157	CcSEcCtD
Vardenafil—Hypotension—Doxorubicin—liver cancer	0.000872	0.00154	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Epirubicin—liver cancer	0.000871	0.00154	CcSEcCtD
Vardenafil—Pain—Epirubicin—liver cancer	0.000863	0.00153	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00085	0.0015	CcSEcCtD
Vardenafil—Insomnia—Doxorubicin—liver cancer	0.000844	0.00149	CcSEcCtD
Vardenafil—Paraesthesia—Doxorubicin—liver cancer	0.000838	0.00148	CcSEcCtD
Vardenafil—Dyspnoea—Doxorubicin—liver cancer	0.000832	0.00147	CcSEcCtD
Vardenafil—Feeling abnormal—Epirubicin—liver cancer	0.000831	0.00147	CcSEcCtD
Vardenafil—Somnolence—Doxorubicin—liver cancer	0.00083	0.00147	CcSEcCtD
Vardenafil—Gastrointestinal pain—Epirubicin—liver cancer	0.000825	0.00146	CcSEcCtD
Vardenafil—Dyspepsia—Doxorubicin—liver cancer	0.000822	0.00145	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000806	0.00143	CcSEcCtD
Vardenafil—Pain—Doxorubicin—liver cancer	0.000798	0.00141	CcSEcCtD
Vardenafil—Abdominal pain—Epirubicin—liver cancer	0.000797	0.00141	CcSEcCtD
Vardenafil—Feeling abnormal—Doxorubicin—liver cancer	0.000769	0.00136	CcSEcCtD
Vardenafil—Gastrointestinal pain—Doxorubicin—liver cancer	0.000763	0.00135	CcSEcCtD
Vardenafil—Hypersensitivity—Epirubicin—liver cancer	0.000743	0.00131	CcSEcCtD
Vardenafil—Abdominal pain—Doxorubicin—liver cancer	0.000738	0.00131	CcSEcCtD
Vardenafil—Asthenia—Epirubicin—liver cancer	0.000724	0.00128	CcSEcCtD
Vardenafil—Pruritus—Epirubicin—liver cancer	0.000714	0.00126	CcSEcCtD
Vardenafil—Diarrhoea—Epirubicin—liver cancer	0.00069	0.00122	CcSEcCtD
Vardenafil—Hypersensitivity—Doxorubicin—liver cancer	0.000688	0.00122	CcSEcCtD
Vardenafil—Asthenia—Doxorubicin—liver cancer	0.00067	0.00118	CcSEcCtD
Vardenafil—Dizziness—Epirubicin—liver cancer	0.000667	0.00118	CcSEcCtD
Vardenafil—Pruritus—Doxorubicin—liver cancer	0.00066	0.00117	CcSEcCtD
Vardenafil—Vomiting—Epirubicin—liver cancer	0.000641	0.00113	CcSEcCtD
Vardenafil—Diarrhoea—Doxorubicin—liver cancer	0.000639	0.00113	CcSEcCtD
Vardenafil—Rash—Epirubicin—liver cancer	0.000636	0.00113	CcSEcCtD
Vardenafil—Dermatitis—Epirubicin—liver cancer	0.000635	0.00112	CcSEcCtD
Vardenafil—Headache—Epirubicin—liver cancer	0.000632	0.00112	CcSEcCtD
Vardenafil—Dizziness—Doxorubicin—liver cancer	0.000617	0.00109	CcSEcCtD
Vardenafil—Nausea—Epirubicin—liver cancer	0.000599	0.00106	CcSEcCtD
Vardenafil—Vomiting—Doxorubicin—liver cancer	0.000593	0.00105	CcSEcCtD
Vardenafil—Rash—Doxorubicin—liver cancer	0.000588	0.00104	CcSEcCtD
Vardenafil—Dermatitis—Doxorubicin—liver cancer	0.000588	0.00104	CcSEcCtD
Vardenafil—Headache—Doxorubicin—liver cancer	0.000585	0.00103	CcSEcCtD
Vardenafil—Nausea—Doxorubicin—liver cancer	0.000554	0.000981	CcSEcCtD
Vardenafil—PDE6G—Disease—STAT3—liver cancer	0.000177	0.000426	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTHFR—liver cancer	0.000176	0.000423	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—KRAS—liver cancer	0.000176	0.000423	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MTOR—liver cancer	0.000176	0.000422	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CB—liver cancer	0.000176	0.000422	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TERT—liver cancer	0.000175	0.000422	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CG—liver cancer	0.000175	0.000421	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK14—liver cancer	0.000173	0.000415	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000171	0.000412	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CD—liver cancer	0.00017	0.000408	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000169	0.000406	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—HRAS—liver cancer	0.000168	0.000403	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TGFB1—liver cancer	0.000168	0.000403	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CPT1B—liver cancer	0.000167	0.000401	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GLUL—liver cancer	0.000167	0.000401	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN1B—liver cancer	0.000165	0.000396	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MYC—liver cancer	0.000165	0.000396	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—RAF1—liver cancer	0.000165	0.000396	CbGpPWpGaD
Vardenafil—PDE6G—Disease—TGFB1—liver cancer	0.000164	0.000395	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AKT1—liver cancer	0.000163	0.000392	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PIK3CA—liver cancer	0.000162	0.000388	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CASP3—liver cancer	0.000162	0.000388	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL2—liver cancer	0.000161	0.000388	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NR1H4—liver cancer	0.000161	0.000387	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CB—liver cancer	0.000161	0.000386	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MTOR—liver cancer	0.000161	0.000386	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL6—liver cancer	0.00016	0.000386	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—RAF1—liver cancer	0.00016	0.000386	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTA3—liver cancer	0.000158	0.00038	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCND1—liver cancer	0.000157	0.000378	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—JUN—liver cancer	0.000157	0.000377	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MTOR—liver cancer	0.000157	0.000376	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CB—liver cancer	0.000157	0.000376	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PRKCE—liver cancer	0.000156	0.000375	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CTNNB1—liver cancer	0.000156	0.000374	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—KRAS—liver cancer	0.000155	0.000373	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CD—liver cancer	0.000154	0.000371	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MMP9—liver cancer	0.000153	0.000367	CbGpPWpGaD
Vardenafil—PDE6G—Disease—KRAS—liver cancer	0.000152	0.000366	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CDKN1A—liver cancer	0.000152	0.000366	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN1B—liver cancer	0.000151	0.000363	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HRAS—liver cancer	0.000149	0.000359	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK8—liver cancer	0.000148	0.000357	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—liver cancer	0.000148	0.000356	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CB—liver cancer	0.000148	0.000356	CbGpPWpGaD
Vardenafil—PDE1B—Disease—APC—liver cancer	0.000148	0.000356	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CASP3—liver cancer	0.000148	0.000355	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IGF2—liver cancer	0.000148	0.000355	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL2—liver cancer	0.000148	0.000355	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDH1—liver cancer	0.000147	0.000354	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN1B—liver cancer	0.000147	0.000353	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—liver cancer	0.000145	0.000349	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTA4—liver cancer	0.000145	0.000348	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CASP3—liver cancer	0.000144	0.000346	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCND1—liver cancer	0.000144	0.000346	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL2—liver cancer	0.000144	0.000346	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—JUN—liver cancer	0.000144	0.000345	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL6—liver cancer	0.000143	0.000344	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—PIK3CA—liver cancer	0.000143	0.000343	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CTNNB1—liver cancer	0.000142	0.000342	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTA2—liver cancer	0.000141	0.000339	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CD—liver cancer	0.000141	0.000339	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCND1—liver cancer	0.00014	0.000337	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—JUN—liver cancer	0.00014	0.000336	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PIK3CA—liver cancer	0.00014	0.000336	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—KRAS—liver cancer	0.00014	0.000336	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MMP9—liver cancer	0.00014	0.000336	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CDKN1A—liver cancer	0.000139	0.000335	CbGpPWpGaD
Vardenafil—PDE1B—Disease—BRAF—liver cancer	0.000139	0.000334	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CTNNB1—liver cancer	0.000139	0.000334	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—liver cancer	0.000138	0.000332	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CSF2—liver cancer	0.000138	0.000332	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—RAF1—liver cancer	0.000138	0.000331	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—liver cancer	0.000137	0.00033	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MMP9—liver cancer	0.000136	0.000327	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTA1—liver cancer	0.000136	0.000327	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—H2AFX—liver cancer	0.000136	0.000327	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL2—liver cancer	0.000136	0.000327	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK8—liver cancer	0.000136	0.000327	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—STAT3—liver cancer	0.000136	0.000326	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CDKN1A—liver cancer	0.000136	0.000326	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NAT2—liver cancer	0.000134	0.000323	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CB—liver cancer	0.000134	0.000323	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK8—liver cancer	0.000132	0.000318	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—HRAS—liver cancer	0.000132	0.000317	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—liver cancer	0.000132	0.000317	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CD—liver cancer	0.00013	0.000313	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HRAS—liver cancer	0.000129	0.000311	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALDOB—liver cancer	0.000129	0.00031	CbGpPWpGaD
Vardenafil—PDE1B—Disease—SERPINE1—liver cancer	0.000129	0.000309	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PIK3CA—liver cancer	0.000128	0.000309	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UGDH—liver cancer	0.000128	0.000308	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MYC—liver cancer	0.000126	0.000303	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TGFB1—liver cancer	0.000126	0.000303	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—RAF1—liver cancer	0.000126	0.000302	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—liver cancer	0.000125	0.000301	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT3—liver cancer	0.000124	0.000299	CbGpPWpGaD
Vardenafil—PDE6G—Disease—IL6—liver cancer	0.000124	0.000298	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2—liver cancer	0.000123	0.000297	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CRABP1—liver cancer	0.000123	0.000296	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TERT—liver cancer	0.000123	0.000296	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CB—liver cancer	0.000123	0.000295	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MTOR—liver cancer	0.000123	0.000295	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—liver cancer	0.000122	0.000294	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT3—liver cancer	0.000121	0.000291	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—EPT1—liver cancer	0.00012	0.000289	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—HRAS—liver cancer	0.000119	0.000286	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—liver cancer	0.000117	0.00028	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—KRAS—liver cancer	0.000117	0.00028	CbGpPWpGaD
Vardenafil—PDE1B—Disease—RAF1—liver cancer	0.000116	0.000279	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MYC—liver cancer	0.000115	0.000277	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1B—liver cancer	0.000115	0.000277	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TGFB1—liver cancer	0.000115	0.000277	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—liver cancer	0.000114	0.000275	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TAT—liver cancer	0.000114	0.000274	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—IL6—liver cancer	0.000114	0.000273	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MTOR—liver cancer	0.000113	0.000272	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CB—liver cancer	0.000113	0.000272	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2—liver cancer	0.000113	0.000271	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MYC—liver cancer	0.000112	0.00027	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KDR—liver cancer	0.000112	0.00027	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TGFB1—liver cancer	0.000112	0.00027	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK14—liver cancer	0.000112	0.000269	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—JUN—liver cancer	0.00011	0.000264	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—ESR1—liver cancer	0.00011	0.000263	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CTNNB1—liver cancer	0.000109	0.000262	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—F2—liver cancer	0.000108	0.00026	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HPGDS—liver cancer	0.000107	0.000258	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CA—liver cancer	0.000107	0.000257	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—KRAS—liver cancer	0.000107	0.000256	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1B—liver cancer	0.000106	0.000256	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDKN1A—liver cancer	0.000106	0.000256	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—liver cancer	0.000105	0.000252	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—KRAS—liver cancer	0.000104	0.00025	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK8—liver cancer	0.000104	0.000249	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—liver cancer	0.000104	0.000249	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CG—liver cancer	0.000104	0.000249	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—APC—liver cancer	0.000104	0.000249	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CTNNB1—liver cancer	0.0001	0.000242	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HRAS—liver cancer	9.91e-05	0.000238	CbGpPWpGaD
Vardenafil—PDE1B—Disease—CDKN1A—liver cancer	9.81e-05	0.000236	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CA—liver cancer	9.79e-05	0.000235	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—BRAF—liver cancer	9.73e-05	0.000234	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSMD10—liver cancer	9.58e-05	0.00023	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PSMA4—liver cancer	9.58e-05	0.00023	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CA—liver cancer	9.54e-05	0.000229	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT3—liver cancer	9.48e-05	0.000228	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL6—liver cancer	9.48e-05	0.000228	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—liver cancer	9.47e-05	0.000228	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GOT2—liver cancer	9.32e-05	0.000224	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—liver cancer	9.23e-05	0.000222	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CD—liver cancer	9.1e-05	0.000219	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HRAS—liver cancer	9.06e-05	0.000218	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CA—liver cancer	9.02e-05	0.000217	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—SERPINE1—liver cancer	9e-05	0.000216	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—KRAS—liver cancer	8.91e-05	0.000214	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HRAS—liver cancer	8.83e-05	0.000212	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP2E1—liver cancer	8.76e-05	0.000211	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STAT3—liver cancer	8.76e-05	0.000211	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—liver cancer	8.75e-05	0.00021	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL6—liver cancer	8.67e-05	0.000209	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL6—liver cancer	8.45e-05	0.000203	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYCS—liver cancer	8.2e-05	0.000197	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CA—liver cancer	8.19e-05	0.000197	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—KRAS—liver cancer	8.14e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MYC—liver cancer	8.14e-05	0.000196	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—RAF1—liver cancer	8.13e-05	0.000195	CbGpPWpGaD
Vardenafil—PDE1B—Disease—TGFB1—liver cancer	8.12e-05	0.000195	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GGT1—liver cancer	8.04e-05	0.000193	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GOT1—liver cancer	8.04e-05	0.000193	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—liver cancer	8e-05	0.000192	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CB—liver cancer	7.93e-05	0.000191	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MTOR—liver cancer	7.93e-05	0.000191	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—liver cancer	7.8e-05	0.000187	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GLUL—liver cancer	7.75e-05	0.000186	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CPT1B—liver cancer	7.75e-05	0.000186	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HRAS—liver cancer	7.57e-05	0.000182	CbGpPWpGaD
Vardenafil—PDE1B—Disease—KRAS—liver cancer	7.52e-05	0.000181	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CA—liver cancer	7.48e-05	0.00018	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NR1H4—liver cancer	7.48e-05	0.00018	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1B—liver cancer	7.45e-05	0.000179	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—liver cancer	7.36e-05	0.000177	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTA3—liver cancer	7.35e-05	0.000177	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CASP3—liver cancer	7.3e-05	0.000175	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2—liver cancer	7.29e-05	0.000175	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL6—liver cancer	7.25e-05	0.000174	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTP1—liver cancer	7.23e-05	0.000174	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—HMOX1—liver cancer	7.13e-05	0.000171	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCND1—liver cancer	7.1e-05	0.000171	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—JUN—liver cancer	7.09e-05	0.00017	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CTNNB1—liver cancer	7.03e-05	0.000169	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HRAS—liver cancer	6.92e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CA—liver cancer	6.91e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MMP9—liver cancer	6.9e-05	0.000166	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CDKN1A—liver cancer	6.87e-05	0.000165	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTA4—liver cancer	6.72e-05	0.000162	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK8—liver cancer	6.71e-05	0.000161	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—liver cancer	6.69e-05	0.000161	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—liver cancer	6.64e-05	0.00016	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL6—liver cancer	6.62e-05	0.000159	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTA2—liver cancer	6.55e-05	0.000158	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HRAS—liver cancer	6.39e-05	0.000154	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTA1—liver cancer	6.32e-05	0.000152	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP1A1—liver cancer	6.29e-05	0.000151	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NAT2—liver cancer	6.25e-05	0.00015	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—liver cancer	6.19e-05	0.000149	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT3—liver cancer	6.13e-05	0.000147	CbGpPWpGaD
Vardenafil—PDE1B—Disease—IL6—liver cancer	6.12e-05	0.000147	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—liver cancer	6.11e-05	0.000147	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALDOB—liver cancer	5.99e-05	0.000144	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—MTHFR—liver cancer	5.87e-05	0.000141	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARA—liver cancer	5.76e-05	0.000138	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CRABP1—liver cancer	5.72e-05	0.000137	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MYC—liver cancer	5.7e-05	0.000137	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TGFB1—liver cancer	5.68e-05	0.000137	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—liver cancer	5.64e-05	0.000136	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KRAS—liver cancer	5.26e-05	0.000127	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HPGDS—liver cancer	5e-05	0.00012	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CG—liver cancer	4.93e-05	0.000119	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CA—liver cancer	4.84e-05	0.000116	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PPARG—liver cancer	4.76e-05	0.000114	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—liver cancer	4.68e-05	0.000113	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HRAS—liver cancer	4.47e-05	0.000108	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSMA4—liver cancer	4.45e-05	0.000107	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PSMD10—liver cancer	4.45e-05	0.000107	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CD—liver cancer	4.33e-05	0.000104	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GOT2—liver cancer	4.33e-05	0.000104	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL6—liver cancer	4.28e-05	0.000103	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—ALB—liver cancer	4.28e-05	0.000103	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP2E1—liver cancer	4.07e-05	9.8e-05	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—liver cancer	3.95e-05	9.5e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYCS—liver cancer	3.81e-05	9.17e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CB—liver cancer	3.78e-05	9.09e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GGT1—liver cancer	3.74e-05	8.99e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GOT1—liver cancer	3.74e-05	8.99e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTP1—liver cancer	3.36e-05	8.08e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—HMOX1—liver cancer	3.31e-05	7.97e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—liver cancer	3.09e-05	7.42e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP1A1—liver cancer	2.93e-05	7.04e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—MTHFR—liver cancer	2.73e-05	6.56e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARA—liver cancer	2.68e-05	6.44e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CA—liver cancer	2.3e-05	5.54e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CG—liver cancer	2.29e-05	5.51e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PPARG—liver cancer	2.21e-05	5.32e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CD—liver cancer	2.02e-05	4.85e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—ALB—liver cancer	1.99e-05	4.78e-05	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—liver cancer	1.88e-05	4.52e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CB—liver cancer	1.76e-05	4.22e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CA—liver cancer	1.07e-05	2.57e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—liver cancer	8.75e-06	2.1e-05	CbGpPWpGaD
